NFKB1 and benign neoplasm: TLR4/NF‐κB pathway has been involved in the inflammatory response related to other cardiovascular diseases, such as acute myocardial infarction and targeting this pathway was suggested to offer an effective therapeutic approach to preserve function of ischaemic heart in patients.39